{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:29:23Z","timestamp":1774686563015,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T00:00:00Z","timestamp":1332720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Colorectal cancer is one of the major neoplasms and a leading cause of cancer death worldwide, and new preventive strategies are needed to lower the burden of this disease. Metformin, a biguanide, which is widely used for treating diabetes mellitus, has recently been suggestive to have a suppressive effect on tumorigenesis and cancer cell growth. In a previous study conducted in non-diabetic subjects, we showed that oral short-term low-dose metformin suppressed the development of colorectal aberrant crypt foci (ACF). ACF have been considered as a useful surrogate biomarker of CRC, although the biological significance of these lesions remains controversial. We devised a prospective randomized controlled trial to evaluate the chemopreventive effect of metformin against metachronous colorectal polyps and the safety of this drug in non-diabetic post-polypectomy patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>This study is a multi-center, double-blind, placebo-controlled, randomized controlled trial to be conducted in non-diabetic patients with a recent history of undergoing colorectal polypectomy. All adult patients visiting the Yokohama City University hospital or affiliated hospitals for polypectomy shall be recruited for the study. Eligible patients will then be allocated randomly into either one of two groups: the metformin group and the placebo group. Patients in the metformin group shall receive oral metformin at 250 mg per day, and those in the placebo group shall receive an oral placebo tablet. At the end of 1 year of administration of metformin\/placebo, colonoscopy will be performed to evaluate the polyp formation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This is the first study proposed to explore the effect of metformin against colorectal polyp formation. Metformin activates AMPK, which inhibits the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway plays an important role in the cellular protein translational machinery and cell proliferation. Patients with type 2 diabetes taking under treatment with metformin have been reported to be at a lower risk of cancer development than those not taking under treatment with metformin. We showed in a previous study that metformin suppressed the formation of human colorectal ACF. We therefore decided to conduct a study to determine whether metformin might suppress the formation of human colorectal polyps.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>This trial has been registered in the University hospital Medical Information Network (UMIN) Clinical Trials Registry as <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/UMIN000006254\" ext-link-type=\"uri\">UMIN000006254<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-12-118","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T08:14:17Z","timestamp":1332749657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Takuma","family":"Higurashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Inayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,26]]},"reference":[{"issue":"2","key":"3139_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322\/caac.20107. Epub 2011 Feb 4","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3139_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1022264002228","volume":"22","author":"WF Anderson","year":"2003","unstructured":"Anderson WF, Umar A, Brawley OW: Colorectal carcinoma in black and white race. Cancer Metastasis Rev. 2003, 22 (1): 67-82. 10.1023\/A:1022264002228. Review","journal-title":"Cancer Metastasis Rev"},{"issue":"27","key":"3139_CR3","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","volume":"329","author":"SJ Winawer","year":"1993","unstructured":"Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993, 329 (27): 1977-1981. 10.1056\/NEJM199312303292701.","journal-title":"N Engl J Med"},{"issue":"6","key":"3139_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gut.48.6.812","volume":"48","author":"F Citarda","year":"2001","unstructured":"Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, Italian Multicentre Study Group: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001, 48 (6): 812-815. 10.1136\/gut.48.6.812.","journal-title":"Gut"},{"issue":"24","key":"3139_CR5","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMc082144","volume":"359","author":"P Maisonneuve","year":"2008","unstructured":"Maisonneuve P, Botteri E, Lowenfels AB: Five-year risk of colorectal neoplasia after negative colonoscopy. N Engl J Med. 2008, 359 (24): 2611-2612. author reply 2612","journal-title":"N Engl J Med"},{"issue":"1","key":"3139_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000108394","volume":"76","author":"D Das","year":"2007","unstructured":"Das D, Arber N, Jankowski JA: Chemoprevention of colorectal cancer. Digestion. 2007, 76 (1): 51-67. 10.1159\/000108394. Epub 2007 Oct 19. Review","journal-title":"Digestion"},{"issue":"11","key":"3139_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMe058038","volume":"352","author":"JM Drazen","year":"2005","unstructured":"Drazen JM: COX-2 inhibitors--a lesson in unexpected problems. N Engl J Med. 2005, 352 (11): 1131-1132. 10.1056\/NEJMe058038. Epub 2005 Feb 15","journal-title":"N Engl J Med"},{"issue":"1","key":"3139_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","volume":"1","author":"FL Meyskens Jr","year":"2008","unstructured":"Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW: Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila). 2008, 1 (1): 32-38. 10.1158\/1940-6207.CAPR-08-0042.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"8","key":"3139_CR9","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/j.1572-0241.2006.00725.x","volume":"101","author":"PJ Limburg","year":"2006","unstructured":"Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ, Sellers TA, Cerhan JR: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol. 2006, 101 (8): 1872-1879. 10.1111\/j.1572-0241.2006.00725.x. Epub 2006 Jun 22","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"3139_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Orsini N, Wolk A: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97 (22): 1679-1687. 10.1093\/jnci\/dji375.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3139_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/gut.2005.073163","volume":"55","author":"EE Frezza","year":"2006","unstructured":"Frezza EE, Wachtel MS, Chiriva-Internati M: Influence of obesity on the risk of developing colon cancer. Gut. 2006, 55 (2): 285-291. 10.1136\/gut.2005.073163. Epub 2005 Oct 20","journal-title":"Gut"},{"issue":"6 Suppl","key":"3139_CR12","doi-asserted-by":"crossref","first-page":"1564S","DOI":"10.1093\/ajcn\/66.6.1564S","volume":"66","author":"E Giovannucci","year":"1997","unstructured":"Giovannucci E, Goldin B: The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997, 66 (6 Suppl): 1564S-1571S.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"3139_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI14178","volume":"108","author":"LA Witters","year":"2001","unstructured":"Witters LA: The blooming of the French lilac. J Clin Invest. 2001, 108 (8): 1105-1107.","journal-title":"J Clin Invest"},{"issue":"11","key":"3139_CR14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/dc08-1171","volume":"31","author":"M Bodmer","year":"2008","unstructured":"Bodmer M, Meier C, Kr\u00e4henb\u00fchl S, Jick SS, Meier CR: Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008, 31 (11): 2086-2091. 10.2337\/dc08-1171. Epub 2008 Sep 9","journal-title":"Diabetes Care"},{"issue":"5754","key":"3139_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005, 310 (5754): 1642-1646. 10.1126\/science.1120781. Epub 2005 Nov 24","journal-title":"Science"},{"issue":"9","key":"3139_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2337\/dc08-2175","volume":"32","author":"G Libby","year":"2009","unstructured":"Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM: New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009, 32 (9): 620-625. Epub 2009 Jun 29","journal-title":"Diabetes Care"},{"issue":"9","key":"3139_CR17","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA: The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009, 52 (9): 1766-10.1007\/s00125-009-1440-6. Epub 2009 Jul 2","journal-title":"Diabetologia"},{"issue":"11","key":"3139_CR18","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1111\/j.1349-7006.2008.00933.x","volume":"99","author":"A Tomimoto","year":"2008","unstructured":"Tomimoto A, Endo H, Sugiyama M, Fujisawa T, Hosono K, Takahashi H, Nakajima N, Nagashima Y, Wada K, Nakagama H, Nakajima A: Metformin suppresses intestinal polyp growth in ApcMin\/+ mice. Cancer Sci. 2008, 99 (11): 2136-2141. 10.1111\/j.1349-7006.2008.00933.x. Epub 2008 Sep 18","journal-title":"Cancer Sci"},{"issue":"7","key":"3139_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mc.20637","volume":"49","author":"K Hosono","year":"2010","unstructured":"Hosono K, Endo H, Takahashi H, Sugiyama M, Uchiyama T, Suzuki K, Nozaki Y, Yoneda K, Fujita K, Yoneda M, Inamori M, Tomatsu A, Chihara T, Shimpo K, Nakagama H, Nakajima A: Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol Carcinog. 2010, 49 (7): 662-671. 10.1002\/mc.20637.","journal-title":"Mol Carcinog"},{"issue":"9","key":"3139_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1158\/1940-6207.CAPR-10-0186","volume":"3","author":"K Hosono","year":"2010","unstructured":"Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, Suzuki K, Iida H, Sakamoto Y, Yoneda K, Koide T, Tokoro C, Abe Y, Inamori M, Nakagama H, Nakajima A: Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila). 2010, 3 (9): 1077-1083. 10.1158\/1940-6207.CAPR-10-0186. Epub 2010 Sep 1","journal-title":"Cancer Prev Res (Phila)"},{"issue":"18","key":"3139_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJM199810293391803","volume":"339","author":"T Takayama","year":"1998","unstructured":"Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998, 339 (18): 1277-1284. 10.1056\/NEJM199810293391803.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"3139_CR22","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/annonc\/mdg722","volume":"14","author":"P Rougier","year":"2003","unstructured":"Rougier P, Mitry E, Rougier P, Mitry E: Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol. 2003, 14 (Suppl 2): ii3-ii5.","journal-title":"Ann Oncol"},{"key":"3139_CR23","unstructured":"The World Medical Association: WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. [http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html], accessed on July 1st, 2011"},{"key":"3139_CR24","unstructured":"The Ministry of Health and Welfare: Ethics Guidelines for Clinical Research. [http:\/\/www.mhlw.go.jp\/general\/seido\/kousei\/i-kenkyu\/rinsyo\/dl\/shishin.pdf], accessed of July 1st, 2011"},{"key":"3139_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D: CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010, 8: 18-10.1186\/1741-7015-8-18.","journal-title":"BMC Med"},{"issue":"11","key":"3139_CR26","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-10-2395","volume":"17","author":"T Takayama","year":"2011","unstructured":"Takayama T, Nagashima H, Maeda M, Nojiri S, Hirayama M, Nakano Y, Takahashi Y, Sato Y, Sekikawa H, Mori M, Sonoda T, Kimura T, Kato J, Niitsu Y: Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps. Clin Cancer Res. 2011, 17 (11): 3803-3811. 10.1158\/1078-0432.CCR-10-2395. Epub 2011 Mar 8","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3139_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","volume":"17","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Ali SM, Sabatini DM: Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005, 17 (6): 596-603. 10.1016\/j.ceb.2005.09.009. Epub 2005 Oct 13","journal-title":"Curr Opin Cell Biol"},{"issue":"48","key":"3139_CR28","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","volume":"25","author":"Y Mamane","year":"2006","unstructured":"Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N: mTOR, translation initiation and cancer. Oncogene. 2006, 25 (48): 6416-6422. 10.1038\/sj.onc.1209888.","journal-title":"Oncogene"},{"issue":"4","key":"3139_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng1265","volume":"35","author":"K Aoki","year":"2003","unstructured":"Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM: Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+\/Delta716 Cdx2+\/- compound mutant mice. Nat Genet. 2003, 35 (4): 323-330. 10.1038\/ng1265. Epub 2003 Nov 16","journal-title":"Nat Genet"},{"issue":"21","key":"3139_CR30","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","volume":"66","author":"M Zakikhani","year":"2006","unstructured":"Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006, 66 (21): 10269-10273. 10.1158\/0008-5472.CAN-06-1500. Epub 2006 Oct 23","journal-title":"Cancer Res"},{"issue":"25","key":"3139_CR31","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","volume":"27","author":"I Ben Sahra","year":"2008","unstructured":"Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y, Bost F: The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene. 2008, 27 (25): 3576-3586. 10.1038\/sj.onc.1211024. Epub 2008 Jan 21","journal-title":"Oncogene"},{"issue":"2","key":"3139_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1677\/ERC-09-0252","volume":"17","author":"C Algire","year":"2010","unstructured":"Algire C, Amrein L, Zakikhani M, Panasci L, Pollak M: Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer. 2010, 17 (2): 351-360. 10.1677\/ERC-09-0252. Print 2010 Jun","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3139_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, Mantzarides M, Foehrenbach H, Pecking AP, Alberini JL: High and typical 18 F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008, 35 (1): 95-99. 10.1007\/s00259-007-0563-6.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-118\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T21:13:11Z","timestamp":1630617191000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-118","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,26]]},"assertion":[{"value":"27 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}